Atherogenic Mechanisms of Electronic Nicotine Delivery Systems

电子尼古丁输送系统的致动脉粥样硬化机制

基本信息

  • 批准号:
    9917380
  • 负责人:
  • 金额:
    $ 74.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-01-01 至 2023-12-31
  • 项目状态:
    已结题

项目摘要

Nicotine is an abundant toxicant in various tobacco products including cigarette smoke, smokeless tobacco, cigars, cigarillos, and hookah. The use of tobacco products increase the risk for atherosclerosis. Although usage of conventional cigarette has steadily declined over the last three decades, usage of new and emerging tobacco products and electronic nicotine delivery systems (ENDS) such as electronic cigarettes (e-cig), e-hookah, and e-cigars has increased exponentially. ENDS aerosolize a solution known as an “e-liquid” (typically a combination of propylene glycol, PG, and vegetable glycerol, VG) that contains a small percentage of nicotine. Although several combustion products and toxins such as CO and tobacco-specific nitrosamines are non-detectable in ENDS, carbonyls including short-chain toxic aldehydes (acrolein, formaldehyde, acetaldehyde, etc.) have been detected in e-cig-derived aerosols up to levels found in tobacco smoke. Our preliminary data suggest that exposure to e-cig or its components, such as acrolein and nicotine (oral exposure) induce macrophage activation (cytokine formation, MMP activation, and apoptosis) and exacerbate atherosclerosis. Conversely, quenching of endogenous aldehydes by feeding with the endogenous dipeptide - carnosine (β-ala-his) or overexpressing carnosine synthase in macrophages prevents atherosclerosis. Our preliminary studies also show that chronic exposure to e-cig, nicotine, and acrolein increase the expression of micro RNA-21 (miR-21) in the aortae of atherogenic mice; and acrolein and nicotine induce miR-21 in macrophages in culture, presumable as an adaptive response to macrophage activation. Based on these observations we hypothesize that miR-21 decreases ENDS-induced atherogenesis by preventing macrophage activation by ENDS-derived aldehydes and nicotine. To test this hypothesis, we will 1) Examine the effect of e-cig on atherogenesis. In LDL receptor- null mice exposed to filtered air, varying proportions of propylene glycol (PG):vegetable glycerin (VG), PG:VG + nicotine, and JUUL-specific e-liquids, we will quantify the time-, dose-, and sex- dependent changes in atherosclerotic lesion formation. We will examine how ENDS and their components affect the plaque composition, the nature, and the stability; 2) Delineate the atherogenic contribution of ENDS-derived aldehydes. We will examine whether quenching of e- liquid and ENDS-derived aldehydes by oral feeding with carnosine or macrophage-specific overexpression of carnosine synthase prevents macrophage activation and atherogenesis and how are these processes regulated by miR-21; 3) Elucidate the atherogenicity of ENDSderived nicotine. We will probe how ENDS activate macrophage α7nAChR, and how macrophage-specific deficiency of α7nAChR affects ENDS-induced macrophage activation and atherogenesis. We will also examine how miR-21 regulates these processes. Overall, the proposed studies will establish novel animal models of ENDS-induced atherosclerosis, and delineate the underling chemical, cellular, and molecular mechanisms of toxicity.
尼古丁是各种烟草制品中丰富的有毒物质,包括香烟烟雾、 无烟烟草、雪茄、小雪茄和水烟。使用烟草制品会增加风险 用于动脉粥样硬化。尽管过去传统卷烟的使用量稳步下降 三十年来,新兴烟草产品的使用和电子尼古丁输送 电子烟 (e-cig)、电子水烟和电子雪茄等系统 (ENDS) 有所增加 呈指数级增长。 ENDS 雾化一种称为“电子液体”的溶液(通常是以下物质的组合) 丙二醇 (PG) 和植物甘油 (VG) 含有少量尼古丁。 尽管一些燃烧产物和毒素,例如一氧化碳和烟草特有的亚硝胺 在 ENDS 中检测不到,羰基化合物包括短链有毒醛类(丙烯醛、 电子烟气溶胶中检测到的甲醛、乙醛等含量高达 存在于烟草烟雾中。我们的初步数据表明,接触电子烟或其组件, 例如丙烯醛和尼古丁(口服暴露)会诱导巨噬细胞活化(细胞因子形成, MMP 激活和细胞凋亡)并加剧动脉粥样硬化。反之,淬火 通过喂食内源性二肽 - 肌肽 (β-ala-his) 或 巨噬细胞中过度表达肌肽合酶可预防动脉粥样硬化。我们的初步 研究还表明,长期接触电子烟、尼古丁和丙烯醛会增加表达 致动脉粥样硬化小鼠主动脉中微小 RNA-21 (miR-21) 的研究;丙烯醛和尼古丁诱导 培养物中巨噬细胞中的 miR-21,可能是对巨噬细胞的适应性反应 激活。基于这些观察,我们假设 miR-21 减少 ENDS 诱导的 通过 ENDS 衍生的醛和尼古丁阻止巨噬细胞活化来防止动脉粥样硬化形成。 为了检验这一假设,我们将 1) 检查电子烟对动脉粥样硬化形成的影响。在LDL受体中- 裸鼠暴露于过滤空气、不同比例的丙二醇(PG):植物甘油 (VG)、PG:VG+尼古丁、JUUL专用烟油,我们将量化时间、剂量、性别 动脉粥样硬化病变形成的依赖性变化。我们将研究 ENDS 及其 成分影响牙菌斑的组成、性质和稳定性; 2) 划定 ENDS 衍生的醛类导致动脉粥样硬化。我们将检查电子是否淬火 通过口服肌肽或巨噬细胞特异性产生液体和 ENDS 衍生的醛 肌肽合酶的过度表达可防止巨噬细胞活化和动脉粥样硬化形成 这些过程是如何受 miR-21 调节的? 3) 阐明ENDS衍生的动脉粥样硬化性 尼古丁。我们将探讨 ENDS 如何激活巨噬细胞 α7nAChR,以及巨噬细胞特异性如何 α7nAChR 缺乏会影响 ENDS 诱导的巨噬细胞活化和动脉粥样硬化形成。我们将 还研究了 miR-21 如何调节这些过程。总体而言,拟议的研究将建立 ENDS 诱导的动脉粥样硬化的新型动物模型,并描述了底层化学物质, 毒性的细胞和分子机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sanjay Srivastava其他文献

Sanjay Srivastava的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sanjay Srivastava', 18)}}的其他基金

Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
  • 批准号:
    10533743
  • 财政年份:
    2020
  • 资助金额:
    $ 74.29万
  • 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
  • 批准号:
    10317034
  • 财政年份:
    2020
  • 资助金额:
    $ 74.29万
  • 项目类别:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
电子尼古丁输送系统的致动脉粥样硬化机制
  • 批准号:
    10082463
  • 财政年份:
    2020
  • 资助金额:
    $ 74.29万
  • 项目类别:
Pathology and Bio-analytics Core
病理学和生物分析核心
  • 批准号:
    10452735
  • 财政年份:
    2018
  • 资助金额:
    $ 74.29万
  • 项目类别:
Pathology and Bio-analytics Core
病理学和生物分析核心
  • 批准号:
    10208901
  • 财政年份:
    2018
  • 资助金额:
    $ 74.29万
  • 项目类别:
Project 2 - Molecular and Cellular Mechanisms of Cardiometabolic Toxicity of VOCs
项目2——VOCs心脏代谢毒性的分子和细胞机制
  • 批准号:
    10693804
  • 财政年份:
    2017
  • 资助金额:
    $ 74.29万
  • 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
  • 批准号:
    10354688
  • 财政年份:
    2017
  • 资助金额:
    $ 74.29万
  • 项目类别:
KC Donnelly Externship–Promotion of Translational/Transdisciplinary Efforts in Graduate & Post-Doctoral Research
KC Donnelly 实习 — 促进研究生的转化/跨学科努力
  • 批准号:
    10382018
  • 财政年份:
    2017
  • 资助金额:
    $ 74.29万
  • 项目类别:
Environmental Exposure and Cardiometabolic Disease
环境暴露与心血管代谢疾病
  • 批准号:
    9904675
  • 财政年份:
    2017
  • 资助金额:
    $ 74.29万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10354693
  • 财政年份:
    2017
  • 资助金额:
    $ 74.29万
  • 项目类别:

相似国自然基金

Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
  • 批准号:
    81570922
  • 批准年份:
    2015
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
  • 批准号:
    81171052
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

In vivo anti cancer natural product synthesis based on reaction with endogenous acrolein
基于与内源性丙烯醛反应的体内抗癌天然产物合成
  • 批准号:
    23KJ0944
  • 财政年份:
    2023
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Prodrug Strategy by Diels-Alder Reaction with Cancer-Derived Acrolein
通过与癌症衍生的丙烯醛进行第尔斯-阿尔德反应的前药策略
  • 批准号:
    23K17971
  • 财政年份:
    2023
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Reactivity of acrolein produced by cancer cells: Application to selective cancer therapy
癌细胞产生的丙烯醛的反应性:在选择性癌症治疗中的应用
  • 批准号:
    21K05269
  • 财政年份:
    2021
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Resarch on prevention of cyclophosphamide cardiotocity by removing acrolein
去除丙烯醛预防环磷酰胺强心死亡的研究
  • 批准号:
    20K08232
  • 财政年份:
    2020
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vivo Click Reaction of Acrolein: Application to In vivo Synthetic Chemistry and Cancer Imaging
丙烯醛的体内点击反应:在体内合成化学和癌症成像中的应用
  • 批准号:
    18K14341
  • 财政年份:
    2018
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Glial activation induced by unsaturated aldehyde acrolein in diabetic retinopathy
不饱和醛丙烯醛诱导糖尿病视网膜病变中的胶质细胞活化
  • 批准号:
    18K09393
  • 财政年份:
    2018
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of acrolein generation in diabetic retinopathy
糖尿病视网膜病变中丙烯醛的生成机制
  • 批准号:
    17K11442
  • 财政年份:
    2017
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of fluorescent probes for acrolein, a product of lipid peroxidation
脂质过氧化产物丙烯醛荧光探针的开发
  • 批准号:
    17H06580
  • 财政年份:
    2017
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Role of acrolein in the pathogenesis of diabetic retinopathy
丙烯醛在糖尿病视网膜病变发病机制中的作用
  • 批准号:
    26462657
  • 财政年份:
    2014
  • 资助金额:
    $ 74.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Treatments of Acrolein-induced Cardiotoxicity
丙烯醛引起的心脏毒性的新疗法
  • 批准号:
    8610016
  • 财政年份:
    2013
  • 资助金额:
    $ 74.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了